Abstract: Age at natural menopause (ANM), a highly heritable phenotype, has been identified to be closely associated with major hormone-related diseases, including breast cancer and gynecological cancers. We previously identified an important role for the transforming growth factor, β receptor II (TGFBR2) gene polymorphisms in breast cancer susceptibility among Asian women. Considering the important role of ANM in breast carcinogenesis, we hypothesized that TGFBR2 signals were involved in the formation of natural menopause.
INTRODUCTION
N atural menopause, which refers to the cessation of ovarian function and the end of the reproductive lifespan, is one of the most important physiological events. 1 Age at natural menopause (ANM) is a heritable phenotype that has been indicated as high heritability (49%-87%) by twins and family studies. 2, 3 Research topics on ANM have been holding intrinsic public health interest all the time, as ANM is associated with numerous health outcomes and might be a marker of aging, mortality, cancer, cardiovascular disease, neurological disease, fracture, diabetes, and osteoporosis. [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] Especially for hormone-related cancers such breast cancer and gynecological cancers, they hold closer relationship with ANM. 14, 17, 18 In general, menopause at an early age, including premature ovarian failure (POF) and early menopause (EM), implies different susceptibility to various disorders. 19, 20 POF, also named primary ovarian insufficiency, is defined as ovarian failure before the age of 40, 21, 22 whereas EM refers to ovarian failure before the age of 45. 23 To better assist women in their reproductive decisions and overall health, it is important to determine factors influencing the timing of menopause.
Our study indicated an important role for the transforming growth factor, β receptor II (TGFBR2) gene polymorphisms in breast cancer susceptibility among Asian women, using a multistage, case-control study design. 24 TGFBR2, a transmembrane serine/threonine protein kinase receptor, is the predominant receptor and coordinator of signal transduction of the TGF-β ligands (TGF-β1, TGF-β2, and TGF-β3). 24 Considering the important role of ANM in breast carcinogenesis, there is considerable biological plausibility for the involvement of TGFBR2 signals in the formation of natural menopause. However, limited information is available about the impact of genetic variations of TGFBR2 gene on ANM, POF, and EM. MiR-518, which targets 3 0 untranslated region of TGFBR2 gene, could influence the expression and function of TGFBR2. Hence, further evaluation of the epigenetic effects of miR-518 on TGFBR2-related trait would be warranted.
We therefore examine the association of TGFBR2 gene and miR-518 gene and menopause timing in a large population of midlife South Han Chinese women. To evaluate the cumulative effect of multiple susceptibility single nucleotide polymorphisms (SNPs), we established a genetic risk score (GRS) by summing the risk alleles. The results might be helpful for properly understanding the role of TGFBR2 and miR-518 genes in the formation of abnormal menopause and carcinogenesis.
MATERIALS AND METHODS

Subjects
In this study, a total of 1844 women were included (age, 43-96 years), who were recruited from a rural Han population by the epidemiological cluster sampling approach in Jiangsu province, China. Detailed information of the subjects in this study has been described previously. 25 Each subject was interviewed faceto-face by trained personnel using a formatted questionnaire to obtain demographic data including age, race, education, occupation, status of smoking and drinking, disease history, menopausal status, and ANM. All participants underwent a complete physical examination and anthropometric measurement. After the interview, each subject provided 3 to 5 mL of venous blood.
Ethics approval for this study was obtained from the institutional review boards of Nanjing Medical University and Third Military Medical University. Written informed consent was obtained from all participants or from the patients' representatives.
SNP Selection and Genotyping
SNPs across TGFBR2 gene and its flanking region with minor allele frequency ³0.05 were searched using the database of CHB (Han Chinese in Beijing, China) population of the International haplotype map (HapMap) Project (HapMap Data Rel 24/phase II Nov 08, on the National Center for Biotechnology Information B36 assembly, dbSNP b126). Linkage disequilibrium between the SNPs was accessed using SNP Annotation and Proxy Search (http://www.broadinstitute.org/ mpg/snap/) to select tagging SNPs (tagSNPs) with r 2 ³ 0.80. 26 Additionally, SNPs in the coding region of microRNAs that target TGFBR2 gene were also completely retrieved. Finally, 9 SNPs in the TGFBR2 gene (rs6785358, rs764522, rs9850060, rs3773645, rs749794, rs3773661, rs11709624, rs1155705, and rs1036096) and 1 SNP in miR-518 gene (rs7256241) were selected. 5 0 -Nuclease TaqMan (Applied Biosystem Incorporation [ABI], Foster City, CA) assays were used to genotype the polymorphisms in 384-well plates on an ABI PRISM 7900HT Sequence Detection system (ABI). The primers and probes for the TaqMan assays were designed using Primer Express Oligo Design software v2.0 (ABI) and are available upon request as TaqMan Pre-Designed SNP Genotyping Assays (ABI). The polymerase chain reaction (PCR) was performed in 5 μL reaction mixtures containing 10 ng of DNA and 2.4 μL of 2Â TaqMan Universal PCR Master Mix (ABI). The PCR conditions used 45 cycles of 50°C for 2 minutes, 95°C for 10 minutes, 95°C for 15 seconds, and then 60°C for 1 minute. The identification of individual genotypes was performed using Sequence Detection Software version 2.0 (ABI). Samples from matched case-control pairs were handled identically and genotyped in the same batch in a blinded fashion. All included SNPs had concordance rates of 100% among duplicates within each platform, and laboratory personnel were blinded to the case-control and quality control status of all samples.
Statistical Analyses
All statistical analyses were conducted with SAS version 9.2 (SAS Institute Inc, Cary, NC). All statistical tests This Article Has Been Retracted were 2-tailed, and P < 0.05 was interpreted as statistically significant unless otherwise indicated. ANM was presented as the means AE SD between different groups. Linear regression was used to derive β coefficients for associations between genotypes and ANM with adjustment for education levels. For associations among POF, EM, and genotypes, odds ratios (ORs), and corresponding 95% confidence intervals (CIs) were determined by unconditional logistic regression models that included adjustment for education levels. Additive, dominant, and recessive models of effect were used for all SNPs. Hardy-Weinberg equilibrium (HWE) assessed allele frequencies using Fisher exact χ 2 test.
To measure the cumulative effect of multiple genetic risk variants, we calculated a GRS by summing the number of risk alleles at each locus (0, 1, or 2). One variant from each independent locus was selected for inclusion in the creation of a GRS. The GRS was categorized using quartile distributions among controls.
RESULTS
Baseline characteristics of study population were listed in of the survey conducted. Of the 1844 women analyzed, 89 subjects were classified as POF cases, whereas 249 were classified as EM cases. In comparisons of cases and controls for POF and EM, no significant differences were detected in distribution of BMI, education levels, smoking, drinking, and hypertension. Compared with controls, POF cases were older (P ¼ 0.015) and more like to have dyslipidemia (P ¼ 0.002). Table 2 shows the effect of the genetic polymorphisms of TGFBR2 and miR-518 for ANM, POF, and EM, which were represented as β coefficients or ORs (95% CIs). In the current study, there was no evidence for departure from HWE for any of the studied SNPs. The carriers of minor allele G of rs7256241 (miR-518) have significantly higher ANM than those of the major allele homozygotes TT (β ¼ 0.385, P ¼ 0.035) ( Table 2) . A marginal association was also detected for the additive model (β ¼ 0.249, P ¼ 0.053), which showed the years of per allele change. Associations of POF, EM, and the genetic polymorphisms of TGFBR2 and miR-518 were also explored using the unconditional logistic regression model. Significant association was observed between the SNP rs3773661 (TGFBR2) and POF risk, with OR (95% CIs) of 0.66 (0.47-0.94) associated with per minor allele C (P ¼ 0.023). Compared with the carriers of major allele homozygotes GG, carriers of minor allele C of rs3773661 have significantly lower risk of POF (OR, 0.65; 95% CI, 0.42-0.99; P ¼ 0.046). The robustness of these findings was evaluated by sensitivity analyses, which excluded smokers, drinkers, and dyslipidemics respectively. All the results above didn't change materially (Supplementary Tables 1 and 2 , http://links.lww. com/MD/A57).
To explore the cumulative effect of multiple genetic risk variants, we established a GRS by summing the number of risk alleles of 10 SNPs. The joint genetic effect of these SNPs on ANM, POF, and EM was then estimated (Supplementary Tables 3 and 4 , http://links.lww.com/MD/A57, Table 3 ). We detected that the quartiles of GRS were significantly associated with POF risk (OR, 1.27; 95% CI, 1.02-1.58; P trend ¼ 0.034).
DISCUSSION
In this large population-based study of 1844 Chinese women, we evaluated the effect of the genetic polymorphisms of TGFBR2 and miR-518 to determine if they are associated with ANM, POF, and EM risk. Our study showed that miR-518 rs7256241 was significantly associated with higher ANM, and TGFBR2 rs3773661 was significantly associated with lower risk of POF. Per quartile of the GRS of 10 SNPs showed a significant association with the risk of POF (P trend ¼ 0.034). This study provides evidence to implicate TGFBR2 and miR-518 gene polymorphisms as novel susceptibility factors for ANM, POF, and EM.
The TGFBR2 gene, located at 3p22, transduces the signal of TGF-β ligands from the cell surface to the cytoplasm and is thus regulating a plethora of physiological and pathological processes including cell proliferation and differentiation, wound healing, extracellular matrix production, immunosuppression, and carcinogenesis. 27 Especially for breast cancer, many studies have identified that TGFBR2 played an important role in carcinogenesis of mammary gland, prognosis, and treatment of breast cancer. [28] [29] [30] The onset of menopause has important implications on women's fertility and health, especially for hormone-related cancers. It's reasonable to explore the plausibility that genes in the transforming growth factor β pathway contribute to the development of natural menopause. Pfeilschifter et al 31 first explored the relationship between concentration of transforming growth factor β I (TGF-β1) in human bone tissue and menopause and detected a significant difference between premenopausal women and postmenopausal women. However, no studies have evaluated the associations between genetic variations of the transforming growth factor β pathway and the development of natural menopause. In the current study, we tested the associations of 9 tagSNPs on the TGFBR2 gene with ANM, POF, and EM risk in 1844 Chinese women. The results indicated that TGFBR2 rs3773661 was significantly associated with 34% lower risk of POF (P ¼ 0.023). Using the Quanto package (http://hydra.usc.edu/gxe/), we found that the power to find such an association for TGFBR2 rs3773661 was up to 80%. SNP rs3773661 is located in the intron of the TGFBR2 gene. Using transcription factor search (TFSEARCH, http://www.cbrc.jp/research/db/TFSEARCH. html), 32 a web-based program that searches for transcription factor binding sites, an Nkx-2.5 binding site was found to be present when the major G allele was present, but not when the minor C allele was. Nkx-2.5 is a transcriptional regulator of iodide transport in thyroid and mammary cells. 33 Previous studies have shown that Nkx-2.5 was expressed in breast cancer cell lines, precardiac mesoderm, myocardial conduction cells, as well as in mammary glands. [34] [35] [36] Together, these data provide considerable biological plausibility of a role for TGFBR2 SNP in natural menopause.
MiR-518, which targeted TGFBR2 gene specifically, could affect the proliferation, cell cycle, apoptosis, and invasion of its host cells. [37] [38] [39] [40] Cai et al 41 identified that miR-518 genes are differentially expressed in esophageal squamous carcinoma (ESC) through miRNA microarray chips and real-time quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) and proposed that it might play important roles in the carcinogenesis and progression of ESC. Then the effect was determined in chondrosarcoma cells, pluripotent cells, and preeclamptic placentas, consecutively. [37] [38] [39] [40] In the current study, we identified that the carriers of minor allele G of rs7256241 (miR-518) had significantly higher ANM than those of the major allele homozygotes TT (β ¼ 0.385, P ¼ 0.035). SNP rs7256241 was predicted to be located in basewise conservation region of 100 vertebrates by PhyloP (http://ccg.vital-it.ch/mga/hg19/ phylop/phylop.html), which supported the finding above. 42 Major strengths of this study include a large sample size and population-based study design. This study had several limitations. First, common bias existed in case-control study when evaluating the potential effect on POF and EM risk. Also, we had limited statistical power to detect evidence of some weak association given the current sample sizes, low allele frequencies, and small-effect sizes. However, this study still contributes originally to the pathogenesis of cessation of ovarian function and the end of the reproductive lifespan.
Conclusively, our study constitutes an initial examination to determine if genetic polymorphisms of TGFBR2 and miR-518 are associated with ANM, POF, and EM risk and provides new insights into the role of TGFBR2 and miR-518 in ANM, POF, and EM. They also imparted a cumulative effect on the risk of POF. Further research on these genetic regions will enhance our understanding of the genetic basis of cessation of ovarian function and the end of the reproductive lifespan, as well as future potential therapeutic targets.
